Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Non-Current Assets (2016 - 2019)

Historic Non-Current Assets for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $17.1 million.

  • Soleno Therapeutics' Non-Current Assets fell 1187.31% to $17.1 million in Q3 2019 from the same period last year, while for Sep 2019 it was $71.1 million, marking a year-over-year decrease of 1220.65%. This contributed to the annual value of $18.5 million for FY2018, which is 1211.24% down from last year.
  • According to the latest figures from Q3 2019, Soleno Therapeutics' Non-Current Assets is $17.1 million, which was down 1187.31% from $17.5 million recorded in Q2 2019.
  • Soleno Therapeutics' Non-Current Assets' 5-year high stood at $22.1 million during Q1 2017, with a 5-year trough of $44000.0 in Q1 2015.
  • Moreover, its 5-year median value for Non-Current Assets was $17.5 million (2019), whereas its average is $11.9 million.
  • In the last 5 years, Soleno Therapeutics' Non-Current Assets surged by 400681.82% in 2016 and then tumbled by 1254.93% in 2019.
  • Soleno Therapeutics' Non-Current Assets (Quarter) stood at $1.8 million in 2015, then dropped by 1.86% to $1.8 million in 2016, then surged by 1092.36% to $21.0 million in 2017, then decreased by 12.11% to $18.5 million in 2018, then dropped by 7.39% to $17.1 million in 2019.
  • Its Non-Current Assets was $17.1 million in Q3 2019, compared to $17.5 million in Q2 2019 and $18.0 million in Q1 2019.